Trial Site Detail

 

Drug:
Ripretinib
Trial:
Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

The First Affiliated Hospital of Chongqing Medical University

     
Chongqing , Chongqing 400016
China

 

Principal Investigator:
 Jun Zhang, MD
Contact:
 +86 136 1766 6067 zjun2323@sina.cn
Activation Status of this Site:
 Active
Notes about this Site:
The First Affiliated Hospital of Chongqing Medical University Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.